Page 4 - Therapeutic Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutic group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutic Group Today - Breaking & Trending Today

MegaLab initiative of IIT Alumni Council to develop and deliver next generation Covid 19 vaccine


New Delhi: IIT Alumni Council announces fourth generation vaccine with ayurvedic adjuvant under MegaLab initiative.
“IIT Alumni Council announces India’s first antigen-free, novel vaccine which is self-limiting, locally manufactured and based on indigenous technology. The preservative-free vaccine is being coupled with an Ayurveda inspired adjuvant which will enhance safety as well as be highly efficacious. The end objective is to deliver a continuously upgradable vaccine which can outpace the virus thus helping to end the pandemic.” said Ravi Sharma, President of the IIT Alumni Council.
“We have made remarkable progress globally in understanding vaccines since August 2020. This has helped eliminate many of the vaccine modalities being investigated and we now know that a multi-pronged approach that will elicit an antibody response which neutralises a wide variety of virus mutants is the right target to pursue. Furthermore, the potential ability to access and build ....

New Delhi , United States , Ravi Sharma , Jayesh Bellare , Arindam Bose , Shantaram Kane , Alumni Council , Ministry Of Ayush , Chairperson Of The Therapeutic Group , Key Thought Leader , Therapeutic Group , Senior Advisor , India Vaccine , Prof Jayesh Bellare , Lifetime Achievement Award , Silver Medallist , Chemical Engineering , Krsnaa Diagnostics , Managing Director , புதியது டெல்ஹி , ஒன்றுபட்டது மாநிலங்களில் , ரவி ஷர்மா , ஜயேஷ் பெல்லாரே , முன்னாள் மாணவர்கள் சபை , அமைச்சகம் ஆஃப் ஆயுஷ் , சிகிச்சை குழு ,

IIT Alumni Council joins race to develop Covid-19 vaccine - The Hindu BusinessLine


May 14, 2021
It has sanctioned ₹300 crore from its Megafund initiative
The IIT Alumni Council has joined the race to develop a preventive vaccine for Covid-19, for which it has sanctioned an immediate ₹300 crore and expects to get an another ₹1,800 crore from its MegaFund initiative.
The vaccine stack – a two-dose vaccine which stops the spread of Covid-19 and prevents infection within a few days of the first dose – is said to be free of attenuated animal virus or deactivated Covid virus or virus fragments. The vaccine would be cold-chain preservation, a move that will further its reach to the key metros.
The IIT Alumni Council is the largest global body of alumni, students and faculty, spread across all the 23 IITs and partnering Technical Institutes of Excellence (TieNet). ....

United States , Ravi Sharma , Arindam Bose , Satish Mehta , Alumni Council , Chairperson Of The Therapeutic Group , Technical Institutes , Key Thought Leader , Therapeutic Group , Senior Advisor , India Vaccine , ஒன்றுபட்டது மாநிலங்களில் , ரவி ஷர்மா , சத்தீஷ் மேத்தா , முன்னாள் மாணவர்கள் சபை , தொழில்நுட்ப நிறுவனங்கள் , சிகிச்சை குழு , இந்தியா தடுப்பூசி ,